NovartisFrom NovartisInvestment Announcements in Mexico Poised to Boost Packaging Machinery DemandFDA Approves Most Expensive Drug in HistoryBrexit Contingency Plans for Pharma IndustryNovartis and Sandoz Recall Non-Compliant Blister PacksNovartis Enters EpiPen Game With Adamis DealWHO Says “Serious Lack” of New Antibiotics in DevelopmentGood News: FDA Approves Gene Therapy for Cancer. Bad News: It Costs $475kTop 10 Patent Cliffs of 2017Trump to Pharma: Lower Prices & Fewer RegulationsSpasm Medicine Goes From $40 to $34,000New Asthma Point-Of-Care TestCalendarized pack earns honors for Novartis, PCI, MWVPage 1 of 2Next Page
